Gene Therapy Could One Day Prevent Facial Birth Defects
WebMD News Archive
Feb. 22, 2000 (Washington) -- Researchers have developed a method to
potentially block the development of cleft palate and other forms of facial
birth defects by injecting specific gene products, or proteins, during a key
time of development. The results, presented at the annual meeting of the
American Association for the Advancement of Science, could lead to gene therapy
to correct these birth defects in the womb, experts say.
In rare cases a fetus can develop a severe defect of the face and head
called holoprosencephaly. The most severe cases develop only one eye in the
middle of the forehead and a large snout-like protrusion, known as a proboscis,
where the nose should be, says lead researcher Jill Helms, DDS, PhD. Helms is
an assistant professor of orthopedic surgery at the University of California,
Most fetuses with this disorder die, but one in 16,000 infants is born with
a less severe -- but still devastating -- form of the disorder. These infants
have a cleft lip and palate, which can be partially corrected by surgery. Like
other facial birth defects, this one is also associated with brain
The researchers knew that pregnant women who received too much vitamin A,
such as those taking the acne medicine Accutane (a modified version of vitamin
A), were much more likely to give birth to children with this birth defect.
Since little was known about the signals that control face and brain
development, Helms and her colleagues began searching for an animal that
developed a similar disorder.
At first, the researchers faced a problem: They needed an animal in which
they could see the effects of various treatments at all stages of
The answer was to use chickens. Too little vitamin A also causes birth
defects, and the research team noticed that depriving developing chickens of
retinoic acid -- a breakdown product of vitamin A -- caused chicks to develop
without the front of the brain and without a beak -- the same parts of the head
and face that are affected in humans with the disorder.